These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18520068)

  • 21. A ¹⁸F-labeled fluorobutyl-substituted spirocyclic piperidine derivative as a selective radioligand for PET Imaging of sigma₁ receptors.
    Maisonial A; Grosse Maestrup E; Fischer S; Hiller A; Scheunemann M; Wiese C; Schepmann D; Steinbach J; Deuther-Conrad W; Wünsch B; Brust P
    ChemMedChem; 2011 Aug; 6(8):1401-10. PubMed ID: 21618432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 1-(4-[18F]fluorobenzyl)-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine for in vivo studies of acetylcholinesterase.
    Lee SY; Choe YS; Sugimoto H; Kim SE; Hwang SH; Lee K; Choi Y; Lee J; Kim B
    Nucl Med Biol; 2000 Nov; 27(8):741-4. PubMed ID: 11150705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is subnanomolar binding affinity required for the in vivo imaging of acetylcholinesterase? Studies on 18F-labeled G379.
    Lee SY; Choe YS; Ryu EK; Iimura Y; Choi Y; Lee KH; Kim BT
    Nucl Med Biol; 2006 Jan; 33(1):91-4. PubMed ID: 16459263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptors.
    Ahamed M; Verbruggen A; Bormans G
    J Labelled Comp Radiopharm; 2013; 56(3-4):207-14. PubMed ID: 24285327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use.
    Liu P; Lin LS; Hamill TG; Jewell JP; Lanza TJ; Gibson RE; Krause SM; Ryan C; Eng W; Sanabria S; Tong X; Wang J; Levorse DA; Owens KA; Fong TM; Shen CP; Lao J; Kumar S; Yin W; Payack JF; Springfield SA; Hargreaves R; Burns HD; Goulet MT; Hagmann WK
    J Med Chem; 2007 Jul; 50(15):3427-30. PubMed ID: 17608398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and radiopharmacological evaluation of 2'-(4-fluorophenyl)-21-[18F]fluoro-20-oxo-11beta,17alpha-dihydroxy-pregn-4-eno[3,2-c]pyrazole as potential glucocorticoid receptor ligand for positron emission tomography (PET).
    Wüst F; Kniess T; Kretzschmar M; Bergmann R
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1303-6. PubMed ID: 15713375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-alpha selective ligand: [18F] propyl pyrazole triol.
    Vijaykumar D; Al-Qahtani MH; Welch MJ; Katzenellenbogen JA
    Nucl Med Biol; 2003 May; 30(4):397-404. PubMed ID: 12767397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
    Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD
    Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
    J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorine-18 isotope labeling for positron emission tomography imaging. Direct evidence for DBPR211 as a peripherally restricted CB1 inverse agonist.
    Chang CP; Huang HL; Huang JK; Hung MS; Wu CH; Song JS; Lee CJ; Yu CS; Shia KS
    Bioorg Med Chem; 2019 Jan; 27(1):216-223. PubMed ID: 30528163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR.
    Wong DF; Kuwabara H; Horti AG; Raymont V; Brasic J; Guevara M; Ye W; Dannals RF; Ravert HT; Nandi A; Rahmim A; Ming JE; Grachev I; Roy C; Cascella N
    Neuroimage; 2010 Oct; 52(4):1505-13. PubMed ID: 20406692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
    Chen YY; Wang X; Zhang JM; Deuther-Conrad W; Zhang XJ; Huang Y; Li Y; Ye JJ; Cui MC; Steinbach J; Brust P; Liu BL; Jia HM
    Bioorg Med Chem; 2014 Oct; 22(19):5270-8. PubMed ID: 25189691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
    Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
    J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric modulation of the cannabinoid CB1 receptor.
    Price MR; Baillie GL; Thomas A; Stevenson LA; Easson M; Goodwin R; McLean A; McIntosh L; Goodwin G; Walker G; Westwood P; Marrs J; Thomson F; Cowley P; Christopoulos A; Pertwee RG; Ross RA
    Mol Pharmacol; 2005 Nov; 68(5):1484-95. PubMed ID: 16113085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new high-yield synthetic route to PET CB1 radioligands [11C]OMAR and its analogs.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3704-9. PubMed ID: 22542014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.
    Ruiu S; Pinna GA; Marchese G; Mussinu JM; Saba P; Tambaro S; Casti P; Vargiu R; Pani L
    J Pharmacol Exp Ther; 2003 Jul; 306(1):363-70. PubMed ID: 12663689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.